M:Corrective
Dermodality M:Corrective is a mild AHA correcting serum. Minimizes pore size, decongests blackheads and lightly exfoliates. Perfect for all skin types.
Description
This serum dramatically enhances and brightens the skin within days of using. It diminishes hyperpigmentation, acne, wrinkles while bringing clarity and balance to the skin. Its is recommended as a pre and post laser treatment to decongest skin glands and reduce irritation caused by laser resurfacing.
Benefits:
Ideal for all skin types
Highly anti-inflammatory
Clarifies, balances, enhances, brightens
Reduces pore size
Decongests skin
Minimizes breakouts
AHA derived from bitter almonds
Pre and post laser treatment
Reduces downtime
Treats aging skin, hyperpigmentation, acne
Directions:
Apply after cleansing and toning. AM & PM use. Can be worn under Vitamin C: Intense, Hyaluronic C Ester (AM) OR under Vitamin A: Intense, HQ Lightening Gel, Revitalizing Booster, Retinol Mixer (PM)
Shipping and Returns
Shipping cost is based on weight. Just add products to your cart and use the Shipping Calculator to see the shipping price.
We want you to be 100% satisfied with your purchase. Items can be returned or exchanged within 30 days of delivery.
There are no question found.
Quick Comparison
| Settings | M:Corrective remove | Dermodality Exfoliating Pads 10% Glycolic remove | Dermodality Restore Eye Cream remove | Mandelic Toner remove | Dermodality Blemish Control Toner remove | Dermodality Blemish Control Kit – 7pcs remove |
|---|---|---|---|---|---|---|
| Name | M:Corrective remove | Dermodality Exfoliating Pads 10% Glycolic remove | Dermodality Restore Eye Cream remove | Mandelic Toner remove | Dermodality Blemish Control Toner remove | Dermodality Blemish Control Kit – 7pcs remove |
| Image |  |  |  |  |  |  |
| Rating | ||||||
| Price | $69.00 | $70.00 | $125.00 | $39.00 | $42.00 | $130.00 |
| Availability | 100 in stock | 100 in stock | 100 in stock | 100 in stock | ||
| Weight | N/A | N/A | N/A | N/A | N/A | N/A |
Rating & Review
There are no reviews yet.